Azanta is an international specialty biopharmaceutical company developing treatments for orphan oncology and women's health indications. Our lead product candidates are Nimoral and Angusta®. To support our operations and to subsidize our development of Nimoral and Angusta® and other orphan oncology and women's health care product candidates, we currently market and distribute a portfolio of specialty pharmaceuticals products pursuant to third party distribution agreements.  Constantly, Azanta looks for new licensing opportunities and partners with products to supplement and broaden the products in our existing portfolio that at the same time addresses unmet treatment needs.  

Click here 

Azanta mission:

Make medicines available because life matters


DisclaimerAll rights reserved ©